electroCore (ECOR) Income from Non-Controlling Interests (2017 - 2018)
electroCore (ECOR) posted Income from Non-Controlling Interests of $55005.0 for Q1 2018, up 123.89% on a QoQ basis from -$230218.0 in Q4 2017.
Analysis
electroCore (ECOR) Income from Non-Controlling Interests (2017 - 2018) Analysis & Trends
electroCore has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $55005.0 in Q1 2018.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $55005.0 in Q1 2018; TTM through Dec 2018 was $55005.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests was $55005.0 for Q1 2018 at electroCore, up from -$230218.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $55005.0 in Q1 2018, with the low at -$230218.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 900,000.00 |
| 10 | electroCore | 85.67 Mn | 75.63 Mn | 8.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 55,005.00 |
| Dec 31, 2017 | -230,218.00 |
| Sep 30, 2017 | -95.00 |
| Jun 30, 2017 | -6,045.00 |